Nektar Therapeutics (NKTR) NASDAQ
76.99
+1.28(+1.69%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
76.99
+1.28(+1.69%)
Currency In USD
| Market Cap | 713.3M |
| Enterprise Value | 847.09M |
| P/E Ratio | -9.52 |
| PEG Ratio | 0.33 |
| Price/Sales Ratio | 28.29 |
| Price/Book Ratio | 17.4 |
| Enterprise/Revenue | 30.71 |
| Enterprise/EBITDA | -13.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -2.97 |
| Operating Margin | -2.38 |
| Return On Assets | -0.59 |
| Return On Equity | -3.99 |
| Revenue | 55.23M |
| Revenue/Share | 2.72 |
| Gross Profit | 55.23M |
| EBITDA | -129.74M |
| Net Income | -164.08M |
| Diluted EPS | -9.73 |
| Total Cash | 245.75M |
| Total Cash/Share | 12.11 |
| Total Debt | 148.91M |
| Total Debt/Equity | 1.66 |
| Current Ratio | 4.97 |
| Book Value Per Share | 4.43 |
| 52-Week Change | 754.5 |
| 52-Week High | 78.81 |
| 52-Week Low | 6.45 |
| Moving Average 50 Days | 62.26 |
| Moving Average 200 Days | 47.48 |
| Average Volume | 1.12M |
| Shares Outstanding | 20.3M |
| % Held by Institutions | 122.89 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | June 09, 2025 |